Bobby Lazzara, MD | Authors

December 13, 2016

In this Medical News Minute developed exclusively for Cancer Network, Dr. Bobby Lazzara discusses recently published research that looks at quality of life outcome measures for elderly breast cancer patients who receive adjuvant chemotherapy.

December 13, 2016

In this Medical News Minute developed exclusively for Cancer Network, Dr. Bobby Lazzara expands on the question of whether statin therapy for breast cancer patients can lower the risk of recurrence and extend relapse-free survival.

November 14, 2016

This Medical News Minute examines a study that found that despite improving outcomes in breast cancer, outcomes among black patients still lag in comparison to white patients.

November 07, 2016

This Medical News Minute examines a recent study that compared two payment models, fee-for-service vs bundled payment, to see if there was any effect on breast cancer outcomes.

October 26, 2016

This Medical News Minute examines a recent report that found that chronic infection with hepatitis B or C virus was associated with an increased risk for lymphoma among HIV patients on antiretroviral therapy.

October 26, 2016

This Medical News Minute outlines efforts by a number of advocacy groups and medical associations urging the CMS to abandon proposed reimbursement cuts to low-dose CT screening for lung cancer.

October 06, 2016

In this Medical News Minute, developed exclusively for Cancer Network, Dr. Bobby Lazzara discusses a recent case report of a 1.7-million-year-old osteosarcoma found in an extinct human lineage.

September 22, 2016

In this Medical News Minute, developed exclusively for Cancer Network, Dr. Bobby Lazzara discusses a recent study that found that surveillance with CA-125 in ovarian cancer patients led to more use of chemotherapy, decreased quality of life, and no improvement in survival.

August 18, 2016

In this Medical News Minute, developed exclusively for Cancer Network, Dr. Bobby Lazzara discusses a recent study that compared EndoPredict and Oncotype DX, which both predict the likelihood of a breast cancer recurrence.

August 11, 2016

In this Medical News Minute, developed exclusively for Cancer Network, Dr. Bobby Lazzara discusses the recent priority review of nivolumab for use in metastatic head and neck cancer.